Predict your next investment

Corporate Venture

See what CB Insights has to offer

Investments

1

About Wilmar Ventures

Wilmar Ventures is a wholly owned investment subsidiary of Wilmar International.

Wilmar Ventures Headquarter Location

Singapore

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Wilmar Ventures News

Wilmar Ventures backs Alzheimer's specialist Accera

Oct 8, 2018

Send to   Wilmar Ventures, an investment arm of Asian agribusiness conglomerate Wilmar International, has led a $50 million funding round for Accera, a developer of treatments for Alzheimer’s disease. The company has also announced that it will change its name to Cerecin and relocate its headquarters from the US to Singapore. Other investors in the round – which comprises equity and non-dilutive grants... To continue reading...

Wilmar Ventures Investments

1 Investments

Wilmar Ventures has made 1 investments. Their latest investment was in Cerecin as part of their Series G on October 10, 2018.

CBI Logo

Wilmar Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/4/2018

Series G

Cerecin

$50M

Yes

4

Date

10/4/2018

Round

Series G

Company

Cerecin

Amount

$50M

New?

Yes

Co-Investors

Sources

4

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.